PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+15.77%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$13.5B
AUM Growth
+$1.89B
(+16%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
335
New
58
Increased
110
Reduced
92
Closed
41
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$159M |
| 2 |
Johnson & Johnson
JNJ
|
$156M |
| 3 |
Chegg
CHGG
|
$85M |
| 4 |
Medtronic
MDT
|
$74.6M |
| 5 |
Humana
HUM
|
$71.3M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$135M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$123M |
| 3 |
Ciena
CIEN
|
$99.1M |
| 4 |
Advanced Micro Devices
AMD
|
$87.5M |
| 5 |
Zoom
ZM
|
$74.1M |
Sector Composition
| 1 | Technology | 35.5% |
| 2 | Healthcare | 19.85% |
| 3 | Financials | 14.53% |
| 4 | Communication Services | 13.92% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
101
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $30.1M | 0.22% |
2,568,385
| – | – |
|
102
Merit Medical Systems
MMSI
$5.34B
| $29.9M | 0.22% |
+688,231
| New | +$29.9M |
|
103
S&P Global
SPGI
$165B
| $29.6M | 0.22% |
82,157
-16,782
| -17% | -$6.05M |
|
104
Tandem Diabetes Care
TNDM
$834M
| $29M | 0.22% |
255,573
+251,140
| +5,665% | +$28.5M |
|
|
RVNC
105
DELISTED
Revance Therapeutics, Inc.
RVNC
| $28.1M | 0.21% |
1,115,804
-167,409
| -13% | -$4.21M |
|
106
Elevance Health
ELV
$72.4B
| $27.5M | 0.2% |
102,234
-3,876
| -4% | -$1.04M |
|
107
Option Care Health
OPCH
$4.7B
| $27.2M | 0.2% |
2,034,549
+2,011,936
| +8,897% | +$26.9M |
|
108
Alcon
ALC
$38.9B
| $26.6M | 0.2% |
+485,237
| New | +$26.6M |
|
109
Agilent Technologies
A
$35.5B
| $26.1M | 0.19% |
258,963
-54,451
| -17% | -$5.5M |
|
110
Insmed
INSM
$30.3B
| $24.5M | 0.18% |
763,376
+303,026
| +66% | +$9.74M |
|
111
James River Group
JRVR
$256M
| $24.5M | 0.18% |
550,000
| – | – |
|
|
SGEN
112
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.5M | 0.18% |
125,000
+10,000
| +9% | +$1.96M |
|
113
First American
FAF
$6.63B
| $24.2M | 0.18% |
475,000
| – | – |
|
114
Amgen
AMGN
$153B
| $24.2M | 0.18% |
95,081
+48,000
| +102% | +$12.2M |
|
115
Enovis
ENOV
$1.75B
| $24.1M | 0.18% |
446,998
-16,950
| -4% | -$915K |
|
116
SS&C Technologies
SSNC
$21.3B
| $23.3M | 0.17% |
384,874
-14,594
| -4% | -$883K |
|
117
Accenture
ACN
$158B
| $23.2M | 0.17% |
102,828
+46,503
| +83% | +$10.5M |
|
118
Taylor Morrison
TMHC
$6.67B
| $22.9M | 0.17% |
932,595
-89,006
| -9% | -$2.19M |
|
119
Intercontinental Exchange
ICE
$100B
| $22.5M | 0.17% |
225,282
-8,542
| -4% | -$855K |
|
120
Icon
ICLR
$14B
| $22.3M | 0.17% |
116,913
-35,958
| -24% | -$6.87M |
|
121
Dolby
DLB
$6.94B
| $21.9M | 0.16% |
330,724
-12,541
| -4% | -$831K |
|
122
BlackLine
BL
$3.26B
| $21.9M | 0.16% |
244,246
+64,103
| +36% | +$5.75M |
|
|
IMMU
123
DELISTED
Immunomedics Inc
IMMU
| $21.7M | 0.16% |
255,632
-1,447,708
| -85% | -$123M |
|
124
IAC Inc
IAC
$2.91B
| $21.4M | 0.16% |
327,447
+232,459
| +245% | +$15.2M |
|
125
RLI Corp
RLI
$6.17B
| $21.4M | 0.16% |
510,000
-25,000
| -5% | -$1.05M |
|